Furiex Pharmaceuticals Inc (FURX) financial statements (2020 and earlier)

Company profile

Business Address 3900 PARAMOUNT PARKWAY
MORRISVILLE, NC 27560
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2926
Cash and cash equivalents2926
Receivables812
Prepaid expense0
Prepaid expense and other current assets0
Total current assets:3838
Noncurrent Assets
Property, plant and equipment00
Intangible assets, net (including goodwill)4949
Goodwill4949
Restricted cash and investments 8
Deferred costs10
Total noncurrent assets:5157
TOTAL ASSETS:8895
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1217
Accounts payable77
Accrued liabilities510
Debt105
Due to related parties1 
Total current liabilities:2322
Noncurrent Liabilities
Long-term debt and lease obligation3235
Long-term debt, excluding current maturities3235
Liabilities, other than long-term debt150
Deferred tax liabilities, net (0)
Due to related parties15 
Other liabilities10
Other undisclosed noncurrent liabilities 0
Total noncurrent liabilities:4735
Total liabilities:7057
Stockholders' equity
Stockholders' equity attributable to parent1838
Common stock00
Additional paid in capital175165
Accumulated deficit(157)(127)
Total stockholders' equity:1838
TOTAL LIABILITIES AND EQUITY:8895

Income statement (P&L) ($ in millions)

12/31/2013
12/31/2012
Gross profit:7141
Operating expenses(95)(81)
Operating loss:(24)(40)
Nonoperating income
(Other Nonoperating income)
00
Interest and debt expense(5)(3)
Loss from continuing operations before income taxes:(29)(43)
Income tax expense(0)(0)
Net loss available to common stockholders, diluted:(30)(43)

Comprehensive Income ($ in millions)

12/31/2013
12/31/2012
Net loss:(30)(43)
Comprehensive loss, net of tax, attributable to parent:(30)(43)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: